Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib

Sorafenib is an inhibitor of a variety of tyrosine kinase receptors used to treat various cancers including hepatocellular, renal cell and thyroid carcinoma. It has been shown to change various targets associated with osteosarcoma, but the detailed mechanism remains unclear. In order to identify key...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Zhehao, Tang, Haoyu, Pan, Yue, Chen, Junquan, Li, Yongping, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929930/
https://www.ncbi.nlm.nih.gov/pubmed/29744300
http://dx.doi.org/10.1002/2211-5463.12428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929930/
https://www.ncbi.nlm.nih.gov/pubmed/29744300
http://dx.doi.org/10.1002/2211-5463.12428

Ejemplares similares